139 related articles for article (PubMed ID: 35690562)
21. Grade I chondrosarcoma of bone: the Münster experience.
Streitbürger A; Ahrens H; Balke M; Buerger H; Winkelmann W; Gosheger G; Hardes J
J Cancer Res Clin Oncol; 2009 Apr; 135(4):543-50. PubMed ID: 18855011
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors and outcome of pelvic, sacral, and spinal chondrosarcomas: a center-based study of 69 cases.
Bergh P; Gunterberg B; Meis-Kindblom JM; Kindblom LG
Cancer; 2001 Apr; 91(7):1201-12. PubMed ID: 11283918
[TBL] [Abstract][Full Text] [Related]
23. IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours.
Amary MF; Bacsi K; Maggiani F; Damato S; Halai D; Berisha F; Pollock R; O'Donnell P; Grigoriadis A; Diss T; Eskandarpour M; Presneau N; Hogendoorn PC; Futreal A; Tirabosco R; Flanagan AM
J Pathol; 2011 Jul; 224(3):334-43. PubMed ID: 21598255
[TBL] [Abstract][Full Text] [Related]
24. Characteristics and Long-Term Outcome of Surgically Managed High-Grade Extremity Chondrosarcoma.
Gulbrandsen TR; Skalitzky MK; Russell MD; An Q; Hasan O; Miller BJ
Iowa Orthop J; 2023; 43(1):71-75. PubMed ID: 37383872
[TBL] [Abstract][Full Text] [Related]
25. Chondrosarcoma of the mobile spine: report on 22 cases.
Boriani S; De Iure F; Bandiera S; Campanacci L; Biagini R; Di Fiore M; Bandello L; Picci P; Bacchini P
Spine (Phila Pa 1976); 2000 Apr; 25(7):804-12. PubMed ID: 10751291
[TBL] [Abstract][Full Text] [Related]
26. Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes.
Denu RA; Yang RK; Lazar AJ; Patel SS; Lewis VO; Roszik J; Livingston JA; Wang WL; Shaw KR; Ratan R; Zarzour MA; Bird J; Raza S; Akdemir KC; Rodon Ahnert J; Subbiah V; Patel S; Conley AP
Clin Cancer Res; 2023 Dec; 29(23):4844-4852. PubMed ID: 37747813
[TBL] [Abstract][Full Text] [Related]
27. What Factors Are Associated with Treatment Outcomes of Japanese Patients with Clear Cell Chondrosarcoma?
Nakayama R; Hayakawa K; Kobayashi E; Endo M; Asano N; Yonemoto T; Kawashima H; Hamada K; Watanabe I; Futani H; Goto T; Nishida Y; Ozaki T
Clin Orthop Relat Res; 2020 Nov; 478(11):2537-2547. PubMed ID: 32297725
[TBL] [Abstract][Full Text] [Related]
28. Intralesional vs. extralesional procedures for low-grade central chondrosarcoma: a systematic review of the literature.
Zoccali C; Baldi J; Attala D; Rossi B; Anelli V; Annovazzi A; Ferraresi V
Arch Orthop Trauma Surg; 2018 Jul; 138(7):929-937. PubMed ID: 29633075
[TBL] [Abstract][Full Text] [Related]
29. Integrating Morphology and Genetics in the Diagnosis of Cartilage Tumors.
de Andrea CE; San-Julian M; Bovée JVMG
Surg Pathol Clin; 2017 Sep; 10(3):537-552. PubMed ID: 28797501
[TBL] [Abstract][Full Text] [Related]
30. Secondary chondrosarcoma arising from osteochondroma: outcomes and prognostic factors.
Tsuda Y; Gregory JJ; Fujiwara T; Abudu S
Bone Joint J; 2019 Oct; 101-B(10):1313-1320. PubMed ID: 31564158
[TBL] [Abstract][Full Text] [Related]
31. Chondrosarcoma of the pelvis. Prognostic factors for 67 patients treated with definitive surgery.
Sheth DS; Yasko AW; Johnson ME; Ayala AG; Murray JA; Romsdahl MM
Cancer; 1996 Aug; 78(4):745-50. PubMed ID: 8756367
[TBL] [Abstract][Full Text] [Related]
32. Dedifferentiated chondrosarcoma--a fatal disease.
Bruns J; Fiedler W; Werner M; Delling G
J Cancer Res Clin Oncol; 2005 Jun; 131(6):333-9. PubMed ID: 15785935
[TBL] [Abstract][Full Text] [Related]
33. [Clear cell chondrosarcoma. Study of 13 clinical cases and review of the literature].
Laporte C; Anract P; Tomeno B; Forest M
Rev Chir Orthop Reparatrice Appar Mot; 1996; 82(8):691-9. PubMed ID: 9097855
[TBL] [Abstract][Full Text] [Related]
34. Chondrosarcoma of bone: a statistical analysis of prognostic factors.
Wang JW; Ger LP; Shih CH; Hsieh MC
J Formos Med Assoc; 1991 Oct; 90(10):998-1003. PubMed ID: 1685183
[TBL] [Abstract][Full Text] [Related]
35. Curettage and cryosurgery for low-grade cartilage tumors is associated with low recurrence and high function.
Mohler DG; Chiu R; McCall DA; Avedian RS
Clin Orthop Relat Res; 2010 Oct; 468(10):2765-73. PubMed ID: 20574801
[TBL] [Abstract][Full Text] [Related]
36. Scapular chondrosarcomas have high rates of local recurrence and metastasis.
Schneiderbauer MM; Blanchard C; Gullerud R; Harmsen WS; Rock MG; Shives TC; Sim FH; Scully SP
Clin Orthop Relat Res; 2004 Sep; (426):232-8. PubMed ID: 15346079
[TBL] [Abstract][Full Text] [Related]
37. Conventional Primary Central Chondrosarcoma of the Pelvis: Prognostic Factors and Outcome of Surgical Treatment in 162 Patients.
Bus MPA; Campanacci DA; Albergo JI; Leithner A; van de Sande MAJ; Gaston CL; Caff G; Mettelsiefen J; Capanna R; Tunn PU; Jeys LM; Dijkstra PDS
J Bone Joint Surg Am; 2018 Feb; 100(4):316-325. PubMed ID: 29462035
[TBL] [Abstract][Full Text] [Related]
38. Chondrosarcomas of the small bones: analysis of 44 patients.
Lesenský J; Matejovsky ZJ; Vcelak J; Ostadal M; Hosova M; Bavelou C; Sioutis S; Bekos A; Mavrogenis AF
Eur J Orthop Surg Traumatol; 2021 Dec; 31(8):1597-1602. PubMed ID: 33811526
[TBL] [Abstract][Full Text] [Related]
39. Low-grade chondrosarcoma of long bones treated with intralesional curettage followed by application of phenol, ethanol, and bone-grafting.
Verdegaal SH; Brouwers HF; van Zwet EW; Hogendoorn PC; Taminiau AH
J Bone Joint Surg Am; 2012 Jul; 94(13):1201-7. PubMed ID: 22760388
[TBL] [Abstract][Full Text] [Related]
40. Prognostic importance of IDH mutations in chondrosarcoma: An individual patient data meta-analysis.
Vuong HG; Ngo TNM; Dunn IF
Cancer Med; 2021 Jul; 10(13):4415-4423. PubMed ID: 34085407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
